GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
10.9773 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCHE, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, POLB, PPARA, PTGS2, SRC, TYR |
9.96516 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCHE, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KDR, MET, MIF, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, XDH |
9.68793 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, POLB, PPARA, PTGS2, SRC, TYR |
9.59459 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, POLB, PPARA, PTGS2, SRC, TYR |
8.17934 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCHE, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, XDH |
7.97052 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, FLT3, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
7.94428 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, FLT3, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
7.94288 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, PTGS2, SRC, TYR |
7.77197 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, MIF, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
7.77197 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
7.77197 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALPL, AURKB, AXL, BCHE, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TYR |
7.77197 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALPL, AURKB, AXL, BCHE, BCL2, CA2, CA9, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, FUT7, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, PTGS2, SRC, TYR |
7.75741 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.30681 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, POLB, PPARA, SRC, TYR |
7.26903 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, FABP3, FABP4, FLT3, MET, PIK3CA, PIK3CB, POLA1, POLB, SRC |
7.13364 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, MIF, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR, XDH |
6.98572 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, FLT3, PTGS2, SRC, TYR |
6.8758 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
6.83832 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, XDH |
6.58265 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
6.57884 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, MIF, PIK3CB, PIM1, POLA1, SRC, TYR |
6.57884 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2, TBXAS1 |
6.57884 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, PPARA, PTGS2, SRC |
6.55687 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, FLT3, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
6.46011 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
6.46011 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH |
6.45294 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2, TBXAS1 |
6.41627 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, DRD3, EGFR, KDR, MIF, PIK3CB, PTGS2, SRC |
6.35107 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.32514 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC |
6.32272 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCHE, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
6.26569 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
6.26569 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MIF, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
6.18393 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCHE, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
6.16583 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PTGS2, SRC |
6.02573 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PTGS2 |
5.92176 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, SRC, XDH |
5.84116 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.68319 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.51234 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FLT3, HSD17B2, KDR, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, SRC, TYR |
5.44181 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD3, EGFR, ERBB2, MET, PIK3CA, PIK3CB, SRC, XDH |
5.43751 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, ALOX5, ALPL, AXL, BCHE, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DRD3, EGFR, ESR1, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
5.43751 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TBXAS1 |
5.39084 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, FABP4, FLT3, KDR, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
5.38432 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGS1, PTGS2, TBXAS1 |
5.36379 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PTGS2, SRC |
5.31603 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MIF, PTGS1, PTGS2, TBXAS1 |
5.29417 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
5.28077 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCHE, BCL2, CA9, CYP1A1, CYP1B1, DRD3, EGFR, FABP3, KDR, POLB, PTGS2, SRC |
5.27367 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, PIK3CA, POLA1, POLB, PTGS2, SRC |
5.27367 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, SRC |
5.25716 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC |
5.13243 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC |
5.11944 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.09254 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PIK3CA, PTGS2, SRC |
4.9846 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, XDH |
4.93022 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.84701 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.77671 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.76426 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC |
4.73644 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.72163 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, SRC |
4.64648 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6061 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD3, EGFR, MMP2, POLB, PPARA, PTGS2, SRC, TYR |
4.53334 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, BCHE, CYP1A1, EGFR, PTGS2, TYR |
4.4669 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD3, KDR, SRC |
4.43798 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, MIF, MMP2, MMP9, PIK3CA, PIK3CB, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC |
4.37378 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
4.33598 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD17B1, HSD17B2 |
4.32207 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, BCL2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
4.30567 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD3, KDR, POLB, SRC |
4.30567 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCHE, BCL2, CA2, EGFR, FLT3, PTGS2, SRC |
4.29582 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, BCL2, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
4.26216 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PTGS2, SRC |
4.25836 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, PIK3CA, PIK3CB, SRC |
4.20343 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD3, FABP3, PPARA |
4.1817 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCHE, BCL2, EGFR, FLT3, PTGS2, SRC |
4.16363 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, XDH |
4.15821 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, BCHE, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
4.1412 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, FABP3, FABP4, MET, PIK3CA, PIK3CB |
4.12381 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, BCL2, EGFR, ERBB2, FABP3, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.11454 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, BCL2, EGFR, ERBB2, FABP3, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
4.11454 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
4.07857 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TBXAS1 |
4.06024 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCHE, BCL2, DRD3, EGFR, ERBB2, ESR1, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SRC, XDH |
4.05022 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCHE, BCL2, DRD3, EGFR, ERBB2, ESR1, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SRC, XDH |
4.03604 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.98403 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, PTGS1, PTGS2, SRC |
3.95969 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.91341 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.89317 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.89317 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
3.821 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD3, EGFR, ERBB2, IGF1R, KDR, MET, MIF, PIK3CA, PIK3CB, POLB, SRC |
3.79973 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
BCHE, CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1 |
3.77297 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA, PTGS1, PTGS2, TBXAS1 |
3.7409 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, POLB, PTGS2, SRC, XDH |
3.63424 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, BCHE, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.59436 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
3.58997 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD3, EGFR, ESR1, PPARA, SRC |
3.58599 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.55907 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, AXL, BCL2, CA2, CACNA1C, CHRM2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SRC, XDH |
3.54152 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, PTGS2, SRC |
3.52047 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
3.51165 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD3, EGFR, ESR1, FABP4, KDR, MET, MIF, MMP12, PPARA, PTGS2 |
3.48983 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD3, ESR1, IGF1R, MET, MIF, MMP9, PTGS2, SRC, XDH |
3.48622 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.4851 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
3.48248 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.46073 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.44995 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, BCHE, CA2, CA7, DRD3, EGFR, PTGS2 |
3.44995 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, BCHE, CA2, CA7, DRD3, EGFR, PTGS2 |
3.44995 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.44995 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, POLB, PTGS2, SRC, XDH |
3.40522 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.39881 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.39612 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CACNA1C, CYP19A1, DRD3, EGFR, ERBB2, MIF, MMP12, MMP9, PIK3CB, PPARA, PTGS2, SRC |
3.3888 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD3, EGFR, ERBB2, MIF, MMP12, PTGS2, SRC |
3.37962 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCHE, BCL2, EGFR, FLT3, PTGS2 |
3.36245 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, DRD3, EGFR, ERBB2, ESR1, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTGS2, SRC, XDH |
3.34967 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD3, FABP3, PPARA |
3.33636 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, BCHE, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
3.33636 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.32644 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.29992 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
3.29886 |
[BP] GO:0019371 |
None
|
PTGS1, PTGS2, TBXAS1 |
3.29257 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.29139 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCHE, BCL2, CYP1A1, EGFR, PTGS2, SRC, TYR |
3.29139 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.29139 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
3.29139 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGS1, PTGS2 |
3.29139 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD3, EGFR, PIK3CB, PTGS2 |
3.29139 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, MIF, PIK3CA, PIK3CB, POLB, PTGS1, PTGS2 |
3.27536 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.25106 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, SRC |
3.25009 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, DRD3, PPARA, PTGS1, PTGS2 |
3.23931 |
[BP] GO:0038128 |
None
|
EGFR, ERBB2, PIK3CA, SRC |
3.21349 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AURKB, AXL, BCHE, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, XDH |
3.19548 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCHE, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
3.19328 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
3.18913 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
3.15807 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, IGF1R, MIF, PIK3CB, SRC |
3.14838 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
3.1288 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.11143 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
3.11143 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
3.11143 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, DRD3, PPARA |
3.10942 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC |
3.06409 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, SRC, XDH |
3.054 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, SRC |
3.02508 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.02406 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, EGFR, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, SRC |
2.98998 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, PPARA, PTGS2, SRC |
2.97847 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PTGS2, SRC |
2.97143 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
BCL2, EGFR, MIF, PIK3CA, PTGS2 |
2.95785 |
[BP] GO:0046854 |
phosphatidylinositol phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.95785 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC |
2.95031 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.95031 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.95031 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.95031 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, MIF, PIK3CB, SRC |
2.93286 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
2.91558 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.9098 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PTGS2, SRC |
2.90745 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCHE, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD3, EGFR, ERBB2, ESR1, FLT3, FUT7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, POLB, PPARA, PTGS2, SRC, TYR, XDH |
2.88046 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.87819 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.87819 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD3, EGFR, MIF, MMP12, SRC |
2.85039 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.84109 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
2.83185 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, ERBB2, FLT3, KDR, MIF, PIK3CB, SRC, XDH |
2.81529 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.80986 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
2.78078 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.78078 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, PTGS2, SRC |
2.78078 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA1, CA2, CACNA1C, CHRM2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLB, PPARA, SRC |
2.77326 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, TYR |
2.77326 |
[BP] GO:0046834 |
lipid phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.76615 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM2, EGFR, PTGS2 |
2.7591 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, DRD3, EGFR, ERBB2, MIF, MMP12, PTGS2, SRC |
2.74739 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, DRD3, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.73443 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.73352 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9 |
2.72099 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, BCHE, CYP1A1, EGFR, PTGS2, TYR |
2.72099 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, FABP3, PIK3CB |
2.72052 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AURKB, AXL, BCHE, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, XDH |
2.71404 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.71404 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCHE, BCL2, CYP1A1, EGFR, PTGS2, SRC, TYR |
2.71133 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.69225 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, AXL, BCL2, CA2, CYP1B1, DRD3, EGFR, KDR, MET, MIF, MMP12, MMP9, PIM1, PTGS2, SRC |
2.69012 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, MET, PIK3CA |
2.66532 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, SRC |
2.66532 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.64374 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PTGS2 |
2.61922 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD3, EGFR, ERBB2, ESR1, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, SRC, XDH |
2.61487 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, AXL, BCHE, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FABP4, FLT3, FUT7, KDR, MET, MIF, MMP2, MMP9, PTGS2, SRC |
2.6132 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.60399 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.59575 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.58705 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
2.58705 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.58547 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.58547 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CYP1B1, EGFR, ERBB2, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC |
2.57968 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.5726 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, BCL2, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.54518 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.53027 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.53027 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCHE, BCL2, CHRM2, CYP1A1, CYP1A2, DRD3, EGFR, MMP12, PTGS2, SRC, TYR |
2.53027 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, BCHE, PTGS2 |
2.52337 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
2.52337 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, EGFR, ERBB2, FLT3, IGF1R, KDR, MIF, PIK3CB, SRC, XDH |
2.51457 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
2.50257 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.50176 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.49575 |
[BP] GO:0033135 |
regulation of peptidyl-serine phosphorylation
|
BCL2, EGFR, MIF, PIK3CA, PTGS2 |
2.49525 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.49005 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.49005 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.47233 |
[BP] GO:0009411 |
response to UV
|
AURKB, BCL2, EGFR, PTGS2, TYR |
2.47033 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, BCL2, DRD3, PIK3CA |
2.46128 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.44019 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, DRD3, EGFR, MIF, MMP12, SRC |
2.44019 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.4305 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.40334 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.40334 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, CSNK2A1, EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.39483 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CYP19A1, EGFR, ESR1, HSD17B2, PTGS2, SRC |
2.3824 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CYP1A1, MIF, POLB, PTGS2 |
2.36888 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD3, MMP9, PTGS2 |
2.36526 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, IGF1R, MET, MIF, MMP12, MMP2, PPARA, PTGS2, SRC, XDH |
2.36119 |
[BP] GO:0006693 |
None
|
MIF, PTGS1, PTGS2 |
2.34997 |
[BP] GO:0006692 |
None
|
MIF, PTGS1, PTGS2 |
2.34997 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD3, MIF, MMP9, PTGS2 |
2.34191 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.33678 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.33491 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, MIF, PIK3CB, SRC |
2.2956 |
[BP] GO:0050900 |
leukocyte migration
|
FUT7, MIF, MMP1, MMP9, PIK3CA, PIK3CB, SRC |
2.2956 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.27733 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, PIK3CA, TYR |
2.27702 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, XDH |
2.27333 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.27265 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.27265 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, MIF, PIK3CB |
2.27265 |
[BP] GO:0050873 |
None
|
ADRB1, FABP4, PTGS2 |
2.27265 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, IGF1R, KDR, MET, MMP9, PTGS2, SRC |
2.24536 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD3, TYR |
2.24511 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, MMP12, MMP2, PPARA, PTGS2, SRC |
2.23556 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
MIF, PTGS1, PTGS2 |
2.23347 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.23347 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, PIK3CA, PIK3CB, SRC |
2.2308 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.23078 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, MIF, MMP9, PIK3CA, PIK3CB, SRC |
2.21819 |
[BP] GO:1901570 |
None
|
ALOX5, MIF, PTGS1, PTGS2 |
2.21375 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, EGFR, PTGS2, SRC |
2.21218 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.201 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.201 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, ESR1, PIK3CB |
2.201 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.1998 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, BCL2, EGFR, ERBB2, ESR1, FLT3, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.19225 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, BCHE, CYP1B1, DRD3, EGFR, PTGS2 |
2.18693 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, MIF, MMP12, SRC |
2.18693 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, MIF, PIK3CB |
2.18693 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF |
2.18693 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTGS2, SRC |
2.18693 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, IGF1R, MIF, PIK3CB, SRC |
2.18391 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2 |
2.18276 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, AURKB, BCL2, EGFR, ERBB2, ESR1, FLT3, MET, MIF, MMP9, PIK3CA, PIK3CB, SRC, XDH |
2.18041 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.17374 |
[BP] GO:0038127 |
None
|
EGFR, ERBB2, PIK3CA, SRC |
2.17374 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.14533 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CYP19A1, CYP1A1, EGFR, ESR1, HSD17B2, MMP2, MMP9, PTGS2, SRC |
2.13911 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.13842 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, MIF, PIK3CA, PIK3CB, SRC |
2.13111 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, MET, PIK3CA, PPARA |
2.13073 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, BCL2, EGFR, ERBB2, MIF, MMP12, PTGS2, SRC |
2.12831 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.12581 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, BCL2, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, XDH |
2.1241 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.11953 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CACNA1C, DRD3, EGFR, ERBB2, MIF, MMP12, PTGS2, SRC |
2.11953 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM2, DRD3, EGFR, PTGS2 |
2.11268 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, POLB, TYR |
2.09922 |
[BP] GO:0010760 |
negative regulation of macrophage chemotaxis
|
CYP19A1, MIF |
2.09879 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.09879 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PTGS2 |
2.0955 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, SRC |
2.08797 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.08797 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, PTGS2, XDH |
2.08527 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, BCHE, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR |
2.07415 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SRC |
2.0686 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, PIK3CA, PIK3CB, SRC |
2.05807 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CYP19A1, DRD3, EGFR, MIF, MMP12, SRC |
2.0534 |
[BP] GO:0030154 |
cell differentiation
|
ADRB1, ALPL, AXL, BCHE, BCL2, CYP1A1, ERBB2, ESR1, FABP4, FLT3, FUT7, KDR, MMP2, MMP9, PTGS2 |
2.0534 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, EGFR, ERBB2, ESR1, FLT3, IGF1R, MMP2, PTGS2, SRC |
2.05072 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, EGFR, ERBB2, FLT3, MIF, PIK3CA, PIK3CB, SRC |
2.04242 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGS2, SRC |
2.03963 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, PIK3CA, PIK3CB, SRC |
2.03887 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, KDR, MET, MIF, PTGS2 |
2.02548 |
[BP] GO:0045124 |
None
|
CA2, EGFR, SRC |
2.02234 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, BCL2, CACNA1C, CSNK2A1, DRD3, EGFR, ERBB2, MIF, MMP12, PTGS2, SRC |
2.02205 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, MIF |
2.02072 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, XDH |
2.0163 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX5, ALPL, AXL, BCHE, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, SRC, TBXAS1, TYR |
3.33636 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, AURKB, BCHE, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
3.1362 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.78811 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, FUT7, HSD17B2, IGF1R, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, TBXAS1, TYR |
2.61469 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM2, CSNK2A1, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, SRC |
2.53027 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AURKB, AXL, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
10.9773 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AURKB, AXL, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PTGS1, PTGS2, SRC, TBXAS1, TYR, XDH |
10.7757 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3965 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, TBXAS1, TYR, XDH |
9.68793 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
7.30681 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.73218 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
6.46011 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC |
6.32514 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AURKB, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, TBXAS1, TYR, XDH |
6.02573 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.87465 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC, TBXAS1 |
5.84116 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, SRC, TBXAS1 |
5.59965 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, NQO2, POLA1, PTGS1, PTGS2, SRC, TBXAS1, XDH |
5.38736 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, NQO2, PTGS1, PTGS2, TBXAS1, TYR, XDH |
5.29417 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TBXAS1, TYR |
5.29417 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.83872 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB |
4.7892 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, TBXAS1, TYR, XDH |
4.50722 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, POLA1, POLB, SRC |
4.49906 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
4.19106 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIM1, SRC |
4.1824 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR |
4.15821 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
4.09973 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA |
4.07508 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.98403 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, SRC |
3.84318 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.78909 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.63424 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.55462 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.50697 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCHE, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MIF, MMP9, NQO2, PTGS2, TYR, XDH |
3.48331 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.44995 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.29257 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, NQO2 |
3.22377 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SRC, XDH |
3.02508 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.02406 |
[MF] GO:0003990 |
acetylcholinesterase activity
|
ACHE, BCHE |
3.02406 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.00658 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.80986 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SRC |
2.69943 |
[MF] GO:0004104 |
cholinesterase activity
|
ACHE, BCHE |
2.64374 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM2, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, PPARA |
2.60399 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SRC, XDH |
2.33339 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, SRC, XDH |
2.3323 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, SRC |
2.21695 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM2, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, PPARA |
2.14711 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA |
2.12831 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.09879 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRB1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, ESR1, FLT3, HSD17B1, IGF1R, KDR, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, POLA1, POLB, PPARA, PTGS1, PTGS2, SRC, TBXAS1, XDH |
2.08797 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM2, DRD3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, PPARA |
2.03963 |